AF
GMAB icon

Advisornet Financial’s Genmab GMAB Stock Holding History

Advisornet Financial’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32
Closed -$957 – 2125
2024
Q1 		$957 Buy
+32
New +$940 ﹤0.01% 1775
2022
Q4 		– Sell
-26
Closed -$1K – 2418
2022
Q3 		$1K Sell
26
-94
-78% -$3.3K ﹤0.01% 1768
2022
Q2 		$4K Sell
120
-90
-43% -$2.92K ﹤0.01% 1544
2022
Q1 		$8K Sell
210
-56
-21% -$1.92K ﹤0.01% 1494
2021
Q4 		$11K Buy
266
+50
+23% +$2.08K ﹤0.01% 1456
2021
Q3 		$9K Buy
+216
New +$9.7K ﹤0.01% 1483

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisornet Financial's GMAB Position: Q2 2024 in Review

Advisornet Financial sold out of Genmab (GMAB) in Q2 2024, closing a stake of 32 shares — an estimated $957 sold.

Advisornet Financial first reported a position in GMAB in Q3 2021 and held it in 6 quarters. The position peaked at $11K in Q4 2021. 219 funds tracked by Wall St. Rank hold GMAB as of Q2 2024.

  • Advisornet Financial reported no remaining Genmab position as of Q2 2024 after selling out during the quarter.
  • Advisornet Financial sold 32 Genmab shares in Q2 2024, an estimated $957.
  • Advisornet Financial first reported a position in Genmab in Q3 2021 and held it in 6 quarters.
  • Advisornet Financial's Genmab position peaked at $11K in Q4 2021.
  • 219 funds tracked by Wall St. Rank held Genmab as of Q2 2024.

Based on Advisornet Financial's 13F filing for Q2 2024, filed 16 Jul 2024.